CCND1 and non-small cell lung carcinoma: In the non-small-cell lung cancer cell line A549, stellettin B ablated the expression of cyclin D1 and phosphorylated Rb and upregulated p27 levels, leading to G1 phase arrest, an increase in cleaved PARP levels, ROS overproduction, and apoptosis [21].